المؤلفون: Li, Xuechun, Bijlsma, Maarten J, Bos, Jens H J, Schuiling-Veninga, Catharina C M, Hak, Eelko

المصدر: Li , X , Bijlsma , M J , Bos , J H J , Schuiling-Veninga , C C M & Hak , E 2023 , ' Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events : A population-based retrospective inception cohort study in the Netherlands ' , BMJ Open , vol. 13 , no. 8 , e068721 . https://doi.org/10.1136/bmjopen-2022-068721Test

مصطلحات موضوعية: Humans, Antihypertensive Agents/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Retrospective Studies, Cardiovascular Diseases/epidemiology, Cohort Studies, Netherlands/epidemiology, Hypertension/drug therapy, Calcium Channel Blockers/therapeutic use, Adrenergic beta-Antagonists/therapeutic use, Diuretics/therapeutic use, Thiazides/therapeutic use, Anti-Arrhythmia Agents/therapeutic use, Primary Prevention, Diabetes Mellitus/drug therapy

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/81d1fecc-3687-4d73-948f-f0cee8118cf4Test

الإتاحة: https://doi.org/10.1136/bmjopen-2022-068721Test
https://hdl.handle.net/11370/81d1fecc-3687-4d73-948f-f0cee8118cf4Test
https://research.rug.nl/en/publications/81d1fecc-3687-4d73-948f-f0cee8118cf4Test
https://pure.rug.nl/ws/files/755175537/e068721.full.pdfTest

المؤلفون: Jensen, Jesper, Poulsen, Mikael Kjær, Petersen, Per Warrer, Gerdes, Bo, Rossing, Kasper, Schou, Morten

المصدر: Jensen , J , Poulsen , M K , Petersen , P W , Gerdes , B , Rossing , K & Schou , M 2023 , ' Prevalence of heart failure phenotypes and current use of therapies in primary care : results from a nationwide study ' , ESC Heart Failure , vol. 10 , no. 3 , pp. 1745-1756 . https://doi.org/10.1002/ehf2.14324Test

مصطلحات موضوعية: Heart failure, Phenotypes, Primary care, Treatment, Stroke Volume, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Heart Failure/drug therapy, Prevalence, Humans, Primary Health Care, Angiotensin Receptor Antagonists/therapeutic use, Adrenergic beta-Antagonists/therapeutic use

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/9d3bbb33-c7b3-4754-be25-9bd3314e31f5Test

الإتاحة: https://doi.org/10.1002/ehf2.14324Test
https://portal.findresearcher.sdu.dk/da/publications/9d3bbb33-c7b3-4754-be25-9bd3314e31f5Test
https://findresearcher.sdu.dk/ws/files/223030533/ESC_Heart_Failure_2023_Jensen_Prevalence_of_heart_failure_phenotypes_and_current_use_of_therapies_in_primary_care_.pdfTest

المؤلفون: Sevre, K., Rist, A., Wachtell, K., Devereux, R.B., Aurigemma, G.P., Smiseth, O.A., Kjeldsen, S.E., Julius, S., Pitt, B., Burnier, M., Kreutz, R., Oparil, S., Mancia, G., Zannad, F.

المصدر: American journal of hypertension, vol. 37, no. 1, pp. 1-14

مصطلحات موضوعية: Humans, Heart Failure/diagnosis, Heart Failure/drug therapy, Stroke Volume/physiology, Diabetes Mellitus, Type 2/complications, Type 2/drug therapy, Ventricular Function, Left, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin Receptor Antagonists/pharmacology, Hypertension/diagnosis, Hypertension/drug therapy, angiotensin receptor blocker, angiotensin receptor neprilysin inhibitor, angiotensin-converting enzyme inhibitor, beta-blocker, blood pressure, heart failure, hypertension, mineralocorticoid receptor antagonist, sodium-glucose cotransporter 2 inhibitor

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37551929; info:eu-repo/semantics/altIdentifier/eissn/1941-7225; https://serval.unil.ch/notice/serval:BIB_962EADA3BC8ETest; urn:issn:0895-7061

الإتاحة: https://doi.org/10.1093/ajh/hpad073Test
https://serval.unil.ch/notice/serval:BIB_962EADA3BC8ETest

المؤلفون: Dobarro, D, Diez-López, C, Couto-Mallón, D, Castrodeza, J, Gómez-Bueno, M, Tobar, J, McKenzie, S, Gonçalves, A, Melendo-Viu, M, Ortiz, C, González-Costello, J

المساهمون: Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE

مصطلحات موضوعية: HSM CAR, Aged, Humans, Middle Aged, Aminobutyrates / therapeutic use, Female, Angiotensin Receptor Antagonists / therapeutic use, Biphenyl Compounds / therapeutic use, Male, Blood Pressure / drug effects, Treatment Outcome, Drug Combinations, Follow-Up Studies, Heart Failure / physiopathology, Heart Failure / therapy, Heart-Assist Devices, Retrospective Studies, Stroke Volume / physiology, Valsartan / therapeutic use, Ventricular Function, Left / physiology

وصف الملف: application/pdf

العلاقة: J Heart Lung Transplant . 2020 Dec;39(12):1499-1501.

الإتاحة: http://hdl.handle.net/10400.17/4528Test

المساهمون: Yuan Lu, Mui Van Zandt, Yun Liu, Jing Li, Xialin Wang, Yong Chen, Zhengfeng Chen, Jaehyeong Cho, Sreemanee Raaj Dorajoo, Mengling Feng, Min-Huei Hsu, Jason C Hsu, Usman Iqbal, Jitendra Jonnagaddala, Yu-Chuan Li, Siaw-Teng Liaw, Hong-Seok Lim, Kee Yuan Ngiam, Phung-Anh Nguyen, Rae Woong Park, Nicole Pratt, Christian Reich, Sang Youl Rhee, Selva Muthu Kumaran Sathappan, Seo Jeong Shin, Hui Xing Tan, Seng Chan You, Xin Zhang, Harlan M Krumholz, Marc A Suchard, Hua Xu, You, Seng Chan

مصطلحات موضوعية: Adolescent, Adrenergic beta-Antagonists / therapeutic use, Adult, Aged, Angiotensin Receptor Antagonists / therapeutic use, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Antihypertensive Agents* / therapeutic use, Australia / epidemiology, Calcium Channel Blockers / therapeutic use, Cohort Studies, Female, Humans, Hypertension* / complications, Hypertension* / drug therapy, Hypertension* / epidemiology, Male, Middle Aged, Thiazides / therapeutic use, Young Adult

العلاقة: JAMA NETWORK OPEN; J03719; OAK-2022-10365; https://ir.ymlib.yonsei.ac.kr/handle/22282913/194345Test; T9992023003; JAMA NETWORK OPEN, Vol.5(3) : e223877, 2022-03

الإتاحة: https://doi.org/10.1001/jamanetworkopen.2022.3877Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194345Test

المساهمون: Seyong Chung, Young-Guk Ko, Jung Sun Kim, Byeong-Keuk Kim, Chul-Min Ahn, Sungha Park, Sung-Jin Hong, Sang-Hak Lee, Donghoon Choi, Ko, Young Guk

مصطلحات موضوعية: Aged, Angiotensin Receptor Antagonists / therapeutic use, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Antihypertensive Agents / adverse effects, Blood Pressure, Cholesterol, LDL, Drug Combinations, Drug Therapy, Combination, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects, Hypertension* / diagnosis, Hypertension* / drug therapy, Male, Risk Factors, Rosuvastatin Calcium / adverse effects, hypercholesterolemia, hypertension, renin–angiotensin system, rosuvastatin calcium

العلاقة: CARDIOLOGY JOURNAL; J03125; OAK-2022-07566; OAK-2022-07567; OAK-2022-07568; OAK-2022-07569; OAK-2022-07570; OAK-2022-07571; OAK-2022-07572; OAK-2022-07573; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191992Test; T202204248; CARDIOLOGY JOURNAL, Vol.29(5) : 815-823, 2022-09

الإتاحة: https://doi.org/10.5603/cj.a2020.0167Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191992Test

المساهمون: Hack-Lyoung Kim, Doyeon Hwang, Jun Hyeok Lee, Hae-Young Lee, Sang-Hyun Ihm, Kwang Il Kim, Jinho Shin, Sungha Park, Dae-Hee Kim, Ki-Chul Sung, Park, Sung Ha

مصطلحات موضوعية: Adrenergic beta-Antagonists / therapeutic use, Angiotensin Receptor Antagonists / therapeutic use, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Antihypertensive Agents / therapeutic use, Calcium Channel Blockers / therapeutic use, Diuretics / therapeutic use, Humans, Hypertension* / chemically induced, Myocardial Infarction* / chemically induced, Stroke* / chemically induced, Stroke* / drug therapy, Stroke* / prevention & control, Cardiovascular risk, Diuretics, Hypertension, Monotherapy, Prognosis

العلاقة: HYPERTENSION RESEARCH; J01017; OAK-2022-06072; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191428Test; https://www.nature.com/articles/s41440-022-00890-8Test; T202205216; HYPERTENSION RESEARCH, Vol.45(5) : 758-768, 2022-05

الإتاحة: https://doi.org/10.1038/s41440-022-00890-8Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191428Test
https://www.nature.com/articles/s41440-022-00890-8Test

المساهمون: Heungjo Kim, Gyunam Park, Jongsung Hahn, Jaewon Oh, Min Jung Chang, Oh, Jae Won

مصطلحات موضوعية: Angiotensin Receptor Antagonists / pharmacology, Angiotensin Receptor Antagonists / therapeutic use, Angiotensin-Converting Enzyme Inhibitors / pharmacology, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, Antihypertensive Agents / therapeutic use, Glucose, Heart Failure* / drug therapy, Humans, Insulins, Neprilysin, Receptors, Angiotensin, Retrospective Studies

العلاقة: SCIENTIFIC REPORTS; J02646; OAK-2022-03287; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189535Test; T202202917; SCIENTIFIC REPORTS, Vol.12(1) : 9703, 2022-06

الإتاحة: https://doi.org/10.1038/s41598-022-13366-zTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/189535Test

المؤلفون: Drobni, Z.D., Michielin, O., Quinaglia, T., Zlotoff, D.A., Zubiri, L., Gilman, H.K., Supraja, S., Merkely, B., Muller, V., Sullivan, R.J., Reynolds, K.L., Pittet, M.J., Jain, R.K., Neilan, T.G.

المصدر: European journal of cancer, vol. 163, pp. 108-118

مصطلحات موضوعية: Angiotensin Receptor Antagonists/pharmacology, Angiotensin Receptor Antagonists/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Antihypertensive Agents/pharmacology, Antihypertensive Agents/therapeutic use, Humans, Hypertension/chemically induced, Hypertension/drug therapy, Immune Checkpoint Inhibitors/adverse effects, Male, Prospective Studies, Renin-Angiotensin System, Retrospective Studies, ACEI, ARB, Immune checkpoint inhibitors, Immune therapy, Renin–angiotensin–aldosterone system blocker

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35065368; info:eu-repo/semantics/altIdentifier/eissn/1879-0852; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_79B5023365590; https://serval.unil.ch/notice/serval:BIB_79B502336559Test; urn:issn:0959-8049; https://serval.unil.ch/resource/serval:BIB_79B502336559.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_79B5023365590Test

الإتاحة: https://doi.org/10.1016/j.ejca.2021.12.024Test
https://serval.unil.ch/notice/serval:BIB_79B502336559Test
https://serval.unil.ch/resource/serval:BIB_79B502336559.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_79B5023365590Test

المؤلفون: Norre, Tobias, Grimm, Daniela, Simonsen, Ulf

المصدر: Norre , T , Grimm , D & Simonsen , U 2022 , ' Sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors, and vericiguat for congestive heart failure therapy ' , Basic & Clinical Pharmacology & Toxicology , vol. 130 , no. 4 , pp. 425-438 . https://doi.org/10.1111/bcpt.13714Test

مصطلحات موضوعية: clinical trials, heart failure, sacubitril/valsartan, sodium-glucose cotransporter 2 inhibitors, vericiguat, GUANYLATE-CYCLASE STIMULATOR, NEPRILYSIN INHIBITION, CARDIOVASCULAR OUTCOMES, NATRIURETIC PEPTIDE, BLOOD-PRESSURE, REDUCED EJECTION FRACTION, DOUBLE-BLIND, NITRIC-OXIDE, valsartan, LCZ696, sacubitril, QUALITY-OF-LIFE, Valsartan/adverse effects, Humans, Tetrazoles/adverse effects, Pyrimidines, Angiotensin Receptor Antagonists/therapeutic use, Glucose/therapeutic use, Aminobutyrates/adverse effects, Treatment Outcome, Biphenyl Compounds, Heart Failure/drug therapy, Sodium, Heterocyclic Compounds, 2-Ring

العلاقة: https://pure.au.dk/portal/en/publications/cacca6d6-d2ec-4c55-afce-79ce59ed97caTest

الإتاحة: https://doi.org/10.1111/bcpt.13714Test
https://pure.au.dk/portal/en/publications/cacca6d6-d2ec-4c55-afce-79ce59ed97caTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306855/pdf/BCPT-130-425.pdfTest